Healthcare is shifting away from hospitals and toward cheaper, at-home and preventive care, and that could leave Baxter’s hospital-focused products under pressure. Reshuffling the business and dealing with supply and quality hiccups may make the transition harder—even as new products and operational fixes could still spark a turnaround.Read more
Baxter could see demand pick up as hospitals return to more normal care and buying patterns, helping its everyday IV and infusion products regain momentum. New leadership and a push into smarter, more connected devices may lift results over time, but quality issues and lingering supply and cost pressures could slow the turnaround.Read more
Key Takeaways New product rollouts, partnerships, and operational changes position Baxter for margin expansion, revenue growth, and transformative gains, with upside potential beyond prevailing analyst expectations. Demographic shifts, global healthcare infrastructure growth, and effective emerging markets strategy support sustained demand and diversified, resilient long-term earnings.Read more
Baxter International Inc., through its subsidiaries, provides a portfolio of healthcare products in the United States. The company operates through three segments: Medical Products & Therapies, Healthcare Systems & Technologies, and Pharmaceuticals. It offers sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products; advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices, as well as advanced equipment for the surgical space comprising operating room integration technologies, precision positioning devices, and other accessories. The company also provides specialty injectable pharmaceuticals, inhaled anesthetics, and drug compounding services. Its products are used in hospitals, nursing homes, rehabilitation centers, ambulatory surgery centers, doctors’ offices, kidney dialysis centers, and patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers. It operates in Eastern Europe, the Middle East, Africa, Latin America, Asia, Western Europe, Canada, Japan, Australia, and New Zealand. Baxter International Inc. was incorporated in 1931 and is headquartered in Deerfield, Illinois.
